Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular and clinical features of a potential immunotherapy target ELK3 in glioma

29 Jul 2022

Abstract excerpt

Glioma represents the most prevalent malignant primary brain cancer, and its treatment remains a tremendous challenge. Novel and efficient molecular targets are therefore required for improving diagnosis, survival prediction, and treatment outcomes. Additionally, some studies have shown that immunity is highly associated with glioma progression. Our study aimed to investigate the clinicopathological features,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to interferon and immune responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35905257
DOI: 10.1097/md.0000000000029544

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular and clinical features of a potential immunotherapy target ELK3 in gliomaPMID 35905257Read ↗

Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in gliomaSemantic proximity Read ↗

Comprehensive Analysis Reveals Promising Immune Target and Prognostic Value of PLK3 in GliomaSemantic proximity Read ↗

PLEKHA4 is a prognostic biomarker and correlated with immune infiltrates in gliomaSemantic proximity Read ↗

Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of gliomaSemantic proximity Read ↗

Integrative analysis identified the key role of LAG3 in T cell exhaustion in gliomaSemantic proximity Read ↗

Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade GliomasSemantic proximity Read ↗

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in GliomasSemantic proximity Read ↗

Identification of Key Differentially Expressed Transcription Factors in GlioblastomaSemantic proximity Read ↗

ETS transcription factor ELK3 in human cancers: An emerging therapeutic targetSemantic proximity Read ↗

LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated MacrophagesSemantic proximity Read ↗

Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in GliomaSemantic proximity Read ↗

Genomic Landscape and Immunological Profile of Glioblastoma in East Asian PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.